Fusion of HepG2 cells with mesenchymal stem cells increases cancer‑associated and malignant properties: an in vivo metastasis model.

Li H, Feng Z, Tsang TC, et al. "Fusion of HepG2 cells with mesenchymal stem cells increases cancer‑associated and malignant properties: an in vivo metastasis model." Oncol Rep. 2014;32(2):539-47.